DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,008,031 | -8.7% | 8,680 | -2.1% | 0.05% | -12.9% |
| Q3 2023 | $2,200,151 | -6.9% | 8,868 | -10.0% | 0.06% | +6.9% |
| Q2 2023 | $2,363,760 | -11.8% | 9,849 | -7.4% | 0.06% | -20.5% |
| Q1 2023 | $2,681,454 | +11.4% | 10,639 | +17.3% | 0.07% | +5.8% |
| Q4 2022 | $2,406,829 | +1.3% | 9,068 | -1.4% | 0.07% | -11.5% |
| Q3 2022 | $2,376,000 | +0.6% | 9,199 | -1.3% | 0.08% | +13.0% |
| Q2 2022 | $2,363,000 | -25.4% | 9,321 | -13.7% | 0.07% | +7.8% |
| Q1 2022 | $3,167,000 | -22.9% | 10,797 | -13.5% | 0.06% | -20.0% |
| Q4 2021 | $4,108,000 | +3.2% | 12,487 | -4.5% | 0.08% | -21.6% |
| Q3 2021 | $3,979,000 | -6.1% | 13,069 | -17.2% | 0.10% | -23.9% |
| Q2 2021 | $4,237,000 | -46.2% | 15,788 | -54.9% | 0.13% | -54.6% |
| Q1 2021 | $7,877,000 | +22.1% | 34,997 | +20.5% | 0.30% | -1.7% |
| Q4 2020 | $6,453,000 | +469.5% | 29,050 | +451.9% | 0.30% | +368.8% |
| Q3 2020 | $1,133,000 | +62.3% | 5,264 | +33.3% | 0.06% | -44.8% |
| Q2 2020 | $698,000 | -5.7% | 3,950 | -26.2% | 0.12% | -71.0% |
| Q1 2020 | $740,000 | -4.0% | 5,349 | +6.5% | 0.40% | +148.4% |
| Q4 2019 | $771,000 | – | 5,022 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |